bile
salt
kinetics
cystic
fibrosis
influence
pancreatic
enzyme
replacement
bile
acid
kinetics
investigated
stable
isotope
dilution
technique
children
ages
months
years
previously
untreated
cystic
fibrosis
patients
clinical
laboratory
evidence
malabsorption
normal
intestinal
mucosal
function
judged
glucose
absorption
intestinal
histology
disaccharidase
levels
normally
functioning
gallbladders
children
maintained
constant
diet
throughout
study
period
fat
intake
averaged
g
per
kg
per
day
administration
pancreatic
enzyme
replacement
fat
excretion
equalled
plus
minus
mean
plus
minus
se
intake
reduced
plus
minus
intake
therapy
total
bile
acid
pool
size
nearly
doubled
enzyme
replacement
plus
minus
micromoles
per
kg
plus
minus
micromoles
per
kg
secondary
bile
acids
comprising
total
pool
therapy
therapy
total
bile
acid
synthesis
changed
little
therapy
equalling
plus
minus
micromoles
per
kg
per
day
total
plus
minus
mg
per
day
without
enzyme
replacement
plus
minus
micromoles
per
kg
per
day
total
plus
minus
milligrams
per
day
enzyme
replacement
confirmed
fecal
excretion
bile
acids
plus
minus
milligrams
bile
acid
per
day
excreted
without
enzymes
compared
plus
minus
milligrams
per
day
enzymes
therapy
fractional
turnover
rate
bile
acid
pool
reduced
plus
minus
per
day
plus
minus
per
day
cholic
acidand
plus
minus
per
day
plus
minus
per
day
chenodeoxycholic
acid
data
indicate
primary
secondary
bile
acids
conserved
within
enterohepatic
circulation
enzyme
therapy
mechanism
regulation
hepatic
bile
acid
synthesis
intact
cystic
fibrosis
however
demonstration
large
amounts
bile
acid
continue
excreted
therapy
suggests
interruption
enterohepatic
circulation
continues
deficiencies
intraluminal
phase
may
persist
enzyme
therapy
disease
